Search research articles
Contact Us
Filters
Showing results (81-90 of 193) with videos related to
Page
of 20
Sort By:
Seminars in Thrombosis and Hemostasis
|
August 23, 2008
Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment
Ronald A Asherson, Ricard Cervera, Joan T Merrill, et al.
European Journal of Rheumatology
|
September 7, 2018
Infodemiology of antiphospholipid syndrome: Merging informatics and epidemiology
Savinio Sciascia, Massimo Radin, Ozan Unlu, et al.
Nature Reviews. Rheumatology
|
August 1, 2020
Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications
Joan T Merrill, Doruk Erkan, Jerald Winakur, et al.
Arthritis and Rheumatism
|
November 6, 2012
A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome
Doruk Erkan, JoAnn Vega, Glendalee Ramón, et al.
Lupus
|
May 27, 2021
16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome
Savino Sciascia, Massimo Radin, Irene Cecchi, et al.
Rheumatology (Oxford, England)
|
April 17, 2018
The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients
Ignasi Rodríguez-Pintó, Gerard Espinosa, Doruk Erkan, et al.
The Journal of Rheumatology
|
February 17, 2007
The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus
Ulas D Bayraktar, Doruk Erkan, Silvia Bucciarelli, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 25, 2024
Reply
Medha Barbhaiya, Stephane Zuily, Guilherme de Jesus, et al.
The Journal of Rheumatology
|
January 5, 2005
Interferon induced digital artery vasculitis
Wouter J M Derksen, Doruk Erkan, Hollis G Potter, et al.
Nature Clinical Practice. Rheumatology
|
August 1, 2007
Subclinical carotid atherosclerosis in a patient with systemic lupus erythematosus
Deborah Alpert, Adrienne Davis, Doruk Erkan, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 193) with videos related to
Sort By:
Page
of 20
Seminars in Thrombosis and Hemostasis
|
August 23, 2008
Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment
Ronald A Asherson, Ricard Cervera, Joan T Merrill, et al.
European Journal of Rheumatology
|
September 7, 2018
Infodemiology of antiphospholipid syndrome: Merging informatics and epidemiology
Savinio Sciascia, Massimo Radin, Ozan Unlu, et al.
Nature Reviews. Rheumatology
|
August 1, 2020
Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications
Joan T Merrill, Doruk Erkan, Jerald Winakur, et al.
Arthritis and Rheumatism
|
November 6, 2012
A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome
Doruk Erkan, JoAnn Vega, Glendalee Ramón, et al.
Lupus
|
May 27, 2021
16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome
Savino Sciascia, Massimo Radin, Irene Cecchi, et al.
Rheumatology (Oxford, England)
|
April 17, 2018
The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients
Ignasi Rodríguez-Pintó, Gerard Espinosa, Doruk Erkan, et al.
The Journal of Rheumatology
|
February 17, 2007
The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus
Ulas D Bayraktar, Doruk Erkan, Silvia Bucciarelli, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 25, 2024
Reply
Medha Barbhaiya, Stephane Zuily, Guilherme de Jesus, et al.
The Journal of Rheumatology
|
January 5, 2005
Interferon induced digital artery vasculitis
Wouter J M Derksen, Doruk Erkan, Hollis G Potter, et al.
Nature Clinical Practice. Rheumatology
|
August 1, 2007
Subclinical carotid atherosclerosis in a patient with systemic lupus erythematosus
Deborah Alpert, Adrienne Davis, Doruk Erkan, et al.
Page
of 20